Navigation Links
Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
Date:5/25/2012

OSAKA, Japan, and SÃO JERÔNIMO, Brazil, May 25, 2012 /PRNewswire/ --



Takeda Pharmaceutical Company Limited (Osaka, Japan, "Takeda") and Multilab Indústria e Comércio de Produtos Farmacêuticos Ltda. (Rio Grande do Sul, Brazil, "Multilab") today jointly announced that both parties have signed an agreement whereby Takeda Farmacêutica Brasil Ltda. (São Paulo, Brazil, "Takeda Brazil"), a wholly-owned subsidiary of Takeda, aims to acquire Multilab.

Takeda expects that the transaction will be finalized by the end of 2Q of its fiscal year 2012. Under the agreement, Takeda Brazil will acquire Multilab in cash for Brazilian Real (BRL) 500 million upfront and up to BRL 40 million in additional future milestone payments to the owners of Multilab. Other financial conditions were not disclosed.

Multilab is a mid-sized pharmaceutical company with annual net revenues of BRL 140 million in 2011. Its business consists of branded generics and OTC (over-the-counter) pharmaceutical products. Retail sales for the company grew in excess of +20% p.a. over the period 2009 - 2011.

Takeda has an established presence in Brazil, manufacturing and marketing both prescription drugs as well as well-known brands such as Neosaldina® (analgesic), Eparema® (digestive) and Nebacetin® (anti-bacterial) comprising its OTC portfolio.

The acquisition of Multilab will position Takeda as one of the top ten pharmaceutical companies in Brazil(1), enriching its offering to better cater to the diverse needs of the Brazilian population. Multilab's leading products include Multigrip®, the country's best-selling OTC product for cold and flu treatment in units(2), which Takeda believes will be an excellent addition to its existing OTC product line in Brazil.

Multilab has well established distribution through regional wholesalers and small
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
2. Takeda Submits New Drug Application in the U.S. for Investigational Type 2 Diabetes Therapy, Fixed-Dose Combination Alogliptin/Metformin
3. U.S. Food and Drug Administration (FDA) Delays Review of Takedas Investigational Type 2 Diabetes Therapies, Alogliptin and Alogliptin/Pioglitazone
4. Takeda Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
5. Takeda Initiates Phase 3 Clinical Trial Program in the United States, Latin America, and Europe for Investigational Type 2 Diabetes Therapy TAK-875
6. Takeda Completes Acquisition and Names New CEO of Nycomed
7. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
8. Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
9. Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
10. Takeda to Acquire Nycomed
11. Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Big Market Research presents a detailed analysis of the ... ( France , Germany , ... Japan . Current scientific views on the Hepatitis ... test volume and sales forecasts by country for HAV NAT, HBV ... HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following ...
(Date:5/5/2015)... , May 5, 2015 ... ( http://www.oramed.com ), a clinical-stage pharmaceutical company focused ... announced today that the company will present at ... Oppenheimer 16th Annual Israeli Conference , ,Date:   ... Nadav Kidron , Chief Executive Officer ,Time: ...
(Date:5/5/2015)... -- E-QURE (Electric Quick Ulcer Remedy) Corp. ... of innovative medical devices in the field of advanced ... and the investment community, covering 2014 - 2015 business ... Bioelectrical Signal Therapy™ (BST) Device for advanced hard-to-heal wounds ... as its plans for commercialization and sale of the ...
Breaking Medicine Technology:2015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3Oramed to Present at Upcoming Conferences 2Oramed to Present at Upcoming Conferences 3E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 2E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 3E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 4E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 5
... Volcano Corporation (NASDAQ: VOLC ) today ... year, the Massachusetts Superior Court rejected claims by ... Medical, that Volcano Corporation and its wholly-owned subsidiary, ... for use in the development of Volcano,s Optical ...
... Tigris Pharmaceuticals, Inc., today announced enrollment of its first ... AFP-464 (aminoflavone prodrug) with or without Faslodex® (fulvestrant) in ... be used to pre-screen patients for a biomarker called ... predict sensitivity to AFP-464. It is ...
Cached Medicine Technology:Statement From Volcano Corporation on Latest St. Jude Lawsuit 2Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients 2Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients 3
(Date:5/5/2015)... year, PolyU researchers garnered two Grand Prizes, two Special ... and four Silver Medals at the world-renowned event. The ... Prize and Gold Medal with the Congratulations of Jury:, ... Investigator: Dr Allan Chee-kooi CHAN, Institute of Textiles and ... the “mannequin” for many tasks involved in apparel design, ...
(Date:5/5/2015)... May 05, 2015 Information ... company serving the federal government, today announced its ... (CCSi). CCSi provides solutions exclusively to federal government ... experience in cyber security, health services, and program ... and industry-relevant credentials as a Third Party Assessment ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 The brains ... accelerated aging that correlate with slower information processing, according ... Graduate School of Public Health . , The ... with type 1 diabetes for cognitive difficulties. If progressive, ... diabetes. The study, funded by the National Institutes ...
(Date:5/5/2015)... Washington, DC (PRWEB) May 05, 2015 ... Amplify Hope Initiative, a new study aimed at determining ... disease patients. RG is an international non-profit providing rare ... genomics sequencing technology, connections to scientists and researchers, and ... or crowdfunding. , “I am excited to see how ...
(Date:5/5/2015)... 2015 Barnabas Health, the state’s largest ... a new healthy cooking video series starring celebrity chef ... Bravo’s Top Chef, teamed up with Barnabas Health to ... living. In support of the series, Barnabas Health ... videos will be showcased on social media. ...
Breaking Medicine News(10 mins):Health News:PolyU wins top prizes in Geneva’s Invention Expo 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 3Health News:PolyU wins top prizes in Geneva’s Invention Expo 4Health News:PolyU wins top prizes in Geneva’s Invention Expo 5Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4Health News:Rare Genomics Institute to Study Impact of Crowdfunding on Rare Diseases 2Health News:Barnabas Health Teams Up With Celebrity Chef Sam Talbot To Launch "Life Is Better Healthy" Cooking Video Series 2Health News:Barnabas Health Teams Up With Celebrity Chef Sam Talbot To Launch "Life Is Better Healthy" Cooking Video Series 3
... Canada are raising a hue and cry over inadequate facilities in ... ill-equipped and many a times patients have to be treated in ... the B.C. Nurses' Union president Deb McPherson said that the status ... have no privacy and no direct access to a washroom, or ...
... reporting that the traditional method of assessing the heart ... danger //of missing one-third of women who are predisposed ... ,Roger Blumenthal, M.D., an associate professor and director ... Hopkins University School of Medicine and its Heart Institute ...
... The health services in Australia’s Townsville will be revolutionized after ... the James Cook University (JCU).// A rural medical school has ... JCU. The University’s new clinic will cost A$ 3 million, ... This will serve to give them experience with regard medicine ...
... to Food science and consumer acceptance in Norway the ... do experts to cheese.// ,The food compared was ... expert dairy assessors. The rating was based on reaction ... was difference of opinion in both factions. As a ...
... Researchers from the Pennsylvania State University are trying to determine ... the zebra fish. The team led by Mark Shriver studied ... change in their key gene plays a major role in ... of Science, may not only help explain why people of ...
... against cancer focusing at the molecular and genetic levels, ... coming under increasing scrutiny.// Now scientists at the University ... these supporting cells are indeed key players in the ... ,These findings were arrived at after studying a ...
Cached Medicine News:Health News:Calcium Levels Could Indicate Future Heart Disease Risk 2Health News:Cancer Cells Trigger Supporting Cells to Turn Cancerous 2
Glucose tubes contain an anti-coagulant and a stabiliser. The tubes are ideal for glucose and lactate determinations....
...
BD Vacutainer® Specialty Tubes - Trace Element - Plastic...
... The inner wall of the serum tube ... these particles activate the coagulation process. Serum ... in the base of the tube; during ... between the serum and the blood cells. ...
Medicine Products: